Literature DB >> 10803002

Adverse reactions to smallpox vaccine: the Israel Defense Force experience, 1991 to 1996. A comparison with previous surveys.

M Haim1, M Gdalevich, D Mimouni, I Ashkenazi, J Shemer.   

Abstract

The aim of the present study was to assess the post-smallpox vaccination complication rate in a cohort of Israel Defense Force recruits enlisted in the calendar years 1991 to 1996 and to compare it with rates reported, in similar age groups, in large surveys during the 1960s. The overall complication rate was 0.4 per 10,000 vaccinees, and the rate of severe complications was very low, similar to previously published data. We conclude that among young healthy adults, vaccination with smallpox vaccine is relatively safe and is associated with a low rate of complications. Severe complications were very rare in this age group in our study. However, the complication rate is increasing with the increased percentage of primary vaccinees.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10803002

Source DB:  PubMed          Journal:  Mil Med        ISSN: 0026-4075            Impact factor:   1.437


  7 in total

1.  Validity of self-assessment of skin reaction after smallpox vaccination.

Authors:  Michael Huerta; Ran D Balicer; Daniel Mimouni; Avi Goldberg; Mda Moshe Furman; Eyal Klement; Ariel Hourvitz; Itamar Grotto
Journal:  Public Health Rep       Date:  2006 Jan-Feb       Impact factor: 2.792

Review 2.  Smallpox vaccine: the good, the bad, and the ugly.

Authors:  Edward A Belongia; Allison L Naleway
Journal:  Clin Med Res       Date:  2003-04

3.  A prospective study of the incidence of myocarditis/pericarditis and new onset cardiac symptoms following smallpox and influenza vaccination.

Authors:  Renata J M Engler; Michael R Nelson; Limone C Collins; Christina Spooner; Brian A Hemann; Barnett T Gibbs; J Edwin Atwood; Robin S Howard; Audrey S Chang; Daniel L Cruser; Daniel G Gates; Marina N Vernalis; Marguerite S Lengkeek; Bruce M McClenathan; Allan S Jaffe; Leslie T Cooper; Steve Black; Christopher Carlson; Christopher Wilson; Robert L Davis
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

Review 4.  The evolution of poxvirus vaccines.

Authors:  Lucas Sánchez-Sampedro; Beatriz Perdiguero; Ernesto Mejías-Pérez; Juan García-Arriaza; Mauro Di Pilato; Mariano Esteban
Journal:  Viruses       Date:  2015-04-07       Impact factor: 5.048

Review 5.  Vaccinia virus, a promising new therapeutic agent for pancreatic cancer.

Authors:  Chadwan Al Yaghchi; Zhongxian Zhang; Ghassan Alusi; Nicholas R Lemoine; Yaohe Wang
Journal:  Immunotherapy       Date:  2015-11-23       Impact factor: 4.196

6.  Why Does Israel Lead the World in COVID-19 Vaccinations? Applying Mass Casualty Event Principles to COVID-19 Vaccination Programs.

Authors:  Carmit Rapaport; Isaac Ashkenazi
Journal:  Int J Environ Res Public Health       Date:  2021-05-18       Impact factor: 3.390

Review 7.  Risks of serious complications and death from smallpox vaccination: a systematic review of the United States experience, 1963-1968.

Authors:  Tomás J Aragón; Skylar Ulrich; Susan Fernyak; George W Rutherford
Journal:  BMC Public Health       Date:  2003-08-11       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.